No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
Javed Butler, MD
PeerDeep Learner: Building AI to Improve Cardiovascular Care
Pierre Elias, MD
PeerIdentifying the Signs and Symptoms of Low Testosterone
Mohit Khera, M.D., M.B.A., M.P.H.
PeerDelivering Transformation: Reducing Maternal Mortality Through Systemic Change
Dena Goffman, MD
PeerMore than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
Daniel Gaudet, MD, PhD
PeerAddressing Hypogonadism with Testosterone Replacement Therapies
Inflammatory Pathways in Severe Asthma: Focus on Mucus Plugs
Addressing Treatment Gaps Among Patients with MDS-Associated Anemia
Managing AKI in ICU Trauma Patients: The Role of a Multidisciplinary Team
APOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
Brian Bergmark, MD
PeerCMV Infection After Transplant: Who’s at Risk and How to Manage?
Confronting the Complexities of Reaching LDL-C Thresholds in Patients with Primary Hyperlipidemia
Michael Bloch, MD
PeerSean Pokorney, MD
Peer